Jaguar Health (JAGX) Assets Average (2015 - 2026)
Jaguar Health's (JAGX) quarterly Assets Average came in at $20.7 million in Q1 2026, down 60.5% year-on-year from $52.4 million in Q1 2025, and down 22.51% on a QoQ basis from $26.7 million in Q4 2025.
Jaguar Health (JAGX) Assets Average (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Assets Average data on file, last reported at $20.7 million in Q1 2026.
- On a quarterly basis, Assets Average fell 60.5% year-over-year to $20.7 million in Q1 2026; TTM through Mar 2026 was $20.7 million, a 60.5% decrease from a year earlier, with the FY2025 full-year figure at $28.7 million, down 44.88% from the prior year.
- Assets Average for Q1 2026 stood at $20.7 million, down from $26.7 million in the prior quarter.
- Over the last five years, Assets Average for JAGX reached as high as $60.0 million in Q3 2024 and fell as low as $20.7 million in Q1 2026.
- Historically, Assets Average has averaged $49.1 million across 5 years, with a median of $51.4 million in 2022.
- Across the five-year window, Assets Average increased 22.93% in 2024 and slumped 60.5% in 2026, its largest moves.
- Year by year, Assets Average stood at $49.4 million in 2022, then slipped by 2.63% to $48.1 million in 2023, then gained by 16.38% to $55.9 million in 2024, then sank by 52.21% to $26.7 million in 2025, then decreased by 22.51% to $20.7 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $20.7 million in Q1 2026, $26.7 million in Q4 2025, and $48.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - | 64.26 Mn |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 40.89 Mn |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn | 8.37 Bn |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn | 26.06 Bn |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn | 40.71 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | 795.91 Mn |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn | 5.05 Bn |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - | 2.30 Bn |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn | 20.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.72 Mn |
| Dec 31, 2025 | 26.74 Mn |
| Sep 30, 2025 | 48.87 Mn |
| Jun 30, 2025 | 49.86 Mn |
| Mar 31, 2025 | 52.44 Mn |
| Dec 31, 2024 | 55.95 Mn |
| Sep 30, 2024 | 59.96 Mn |
| Jun 30, 2024 | 58.42 Mn |
| Mar 31, 2024 | 53.08 Mn |
| Dec 31, 2023 | 48.07 Mn |
| Sep 30, 2023 | 48.78 Mn |
| Jun 30, 2023 | 54.55 Mn |
| Mar 31, 2023 | 52.19 Mn |
| Dec 31, 2022 | 49.37 Mn |
| Sep 30, 2022 | 50.59 Mn |
| Jun 30, 2022 | 51.40 Mn |
| Mar 31, 2022 | 53.09 Mn |
| Dec 31, 2021 | 56.26 Mn |
| Sep 30, 2021 | 64.40 Mn |
| Jun 30, 2021 | 69.13 Mn |